Ocata Therapeutics Inc fka OCAT

[farviewhill]

They are insulting our intelligence again. In typical Rabin fashion, some nice sounding fluff when in no way could they RS and uplist now anyways for many reasons, the least of which is the stock price and the approved proxy and the most of which is the outstanding litigation with Camofi and the SEC which would preclude it.

Great to know he still feels the clinicals are going great. That's crucial, but please, we knew things would develop this way quite awhile ago and be re-visited come first quarter of 2013, in all likelihood.

Having said all that, don't lose faith at all in the company, it's just taking time to get matters straightened out.